Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Relapsing Multiple Sclerosis
Related studies linked through entity extraction aliases.
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Ocrevus in Relapsing Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab
- Status
- COMPLETED
- Phase
- PHASE3
Study of Evobrutinib in Participants With RMS (evolutionRMS 2)
- Status
- TERMINATED
- Phase
- PHASE3
Study of Evobrutinib in Participants With RMS (evolutionRMS 1)
- Status
- TERMINATED
- Phase
- PHASE3
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
- Status
- COMPLETED
- Phase
- PHASE3
Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS)
- Status
- WITHDRAWN
- Phase
- PHASE2
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Status
- RECRUITING
- Phase
- PHASE3
Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE4
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab
- Status
- COMPLETED
- Phase
- PHASE2
Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™
- Status
- COMPLETED
- Phase
- PHASE4